Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study

DOI Full Paper Access

69

Citations

33

References

2019

Year

Emmanuel Monnet, Ernest Choy, Iain B. McInnes, Tamta Kobakhidze, Kathy de Graaf, Philippe Jacqmin, G Lapeyre, Cristina de Min

Annals of the Rheumatic Diseases

References

	Year	Citations

Page 1